Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dupuy

Showing results (151-160 of 225) with videos related to

Pageof 23
Sort By:
Clinical Chemistry and Laboratory Medicine|July 4, 2001
Discrepancies between apolipoprotein E phenotyping and genotyping in the elderlyA M Dupuy, S Badiou, K Ritchie, et al.
Atherosclerosis|May 7, 2003
Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?S Badiou, C Merle De Boever, A M Dupuy, et al.
International Journal of Sports Medicine|May 15, 2007
Effects of a supplementation during exercise and recoveryC Thomas, S Perrey, H Ben Saad, et al.
The Journal of Clinical Investigation|August 1, 1992
Bronchodilator action of inhaled nitric oxide in guinea pigsP M Dupuy, S A Shore, J M Drazen, et al.
The Neuroradiology Journal|September 14, 2013
Early encephalic toxicity after inadvertent intrathecal injection of low osmolar contrast mediumL Lonjaret, T Geeraerts, J-F Albucher, et al.
Transplantation Proceedings|January 3, 2001
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemiaM D Tur, V Garrigue, C Vela, et al.
Transplantation Proceedings|September 27, 2005
High prevalence of small dense LDL as an underestimated component of heart transplantation-induced dyslipidemia: potential role in graft coronary vasculopathy?S Badiou, V Perez, A M Dupuy, et al.
Atherosclerosis|December 7, 2010
Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C StudyC Straczek, M Tafflet, P Barberger-Gateau, et al.
Clinical Laboratory|February 21, 2003
Apolipoprotein CIII and highly active antiretroviral therapy (HAART)-induced hypertriglyceridemiaS Badiou, A M Dupuy, V Baillat, et al.
Chemical & Pharmaceutical Bulletin|September 18, 2001
Synthesis and in vitro cytotoxic evaluation of new derivatives of pyrido[1,2-a]benzimidazolic ring system: the pyrido[1',2':1,2]imidazo[4,5-h]quinazolinesM Dupuy, F Pinguet, O Chavignon, et al.
Pageof 23

Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Clinical Chemistry and Laboratory Medicine|July 4, 2001
Discrepancies between apolipoprotein E phenotyping and genotyping in the elderlyA M Dupuy, S Badiou, K Ritchie, et al.
Atherosclerosis|May 7, 2003
Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?S Badiou, C Merle De Boever, A M Dupuy, et al.
International Journal of Sports Medicine|May 15, 2007
Effects of a supplementation during exercise and recoveryC Thomas, S Perrey, H Ben Saad, et al.
The Journal of Clinical Investigation|August 1, 1992
Bronchodilator action of inhaled nitric oxide in guinea pigsP M Dupuy, S A Shore, J M Drazen, et al.
The Neuroradiology Journal|September 14, 2013
Early encephalic toxicity after inadvertent intrathecal injection of low osmolar contrast mediumL Lonjaret, T Geeraerts, J-F Albucher, et al.
Transplantation Proceedings|January 3, 2001
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemiaM D Tur, V Garrigue, C Vela, et al.
Transplantation Proceedings|September 27, 2005
High prevalence of small dense LDL as an underestimated component of heart transplantation-induced dyslipidemia: potential role in graft coronary vasculopathy?S Badiou, V Perez, A M Dupuy, et al.
Atherosclerosis|December 7, 2010
Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C StudyC Straczek, M Tafflet, P Barberger-Gateau, et al.
Clinical Laboratory|February 21, 2003
Apolipoprotein CIII and highly active antiretroviral therapy (HAART)-induced hypertriglyceridemiaS Badiou, A M Dupuy, V Baillat, et al.
Chemical & Pharmaceutical Bulletin|September 18, 2001
Synthesis and in vitro cytotoxic evaluation of new derivatives of pyrido[1,2-a]benzimidazolic ring system: the pyrido[1',2':1,2]imidazo[4,5-h]quinazolinesM Dupuy, F Pinguet, O Chavignon, et al.
Pageof 23